Furthermore, combined high expression of FGFR1 and FGFR2 protein characterized a subtype of MPNST with better OS, while increased FGFR4 protein expression predicted worse disease-free survival (DFS). The gene discussed is FGFR4; the disease is malignant peripheral nerve sheath tumor.